Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-42.48	65.41	113.73
Graham Fair Price	473.47	69136.30	12055.86
PEG	-99.90	< 0.005	1.04
Price/Book	1.82	0.52	0.51
Price/Cash Flow	-96.56	1.46	42.56
Prices/Earnings	-96.84	3.46	-109.35
Price/Sales	-81.23	0.94	5.01
Price/FCF	-96.56	1.46	42.56
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	23.55	0.97	0.78
Operating Margin	-64.84	0.09	0.25
ROA	2959.12	< 0.005	< 0.005
ROE	< 0.005	0.04	3120.74
ROIC	< 0.005	< 0.005	1.21
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	1.41	-98.62
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.15	0.93	506.14
EPS QOQ	-1.05	33.55	3090.29
FCF QOQ	-0.86	28.94	3276.00
Revenue QOQ	0.50	4.48	791.23
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	491.48	120.87	-75.41
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.75	0.75	0.23
Quick Ratio	0.73	0.88	20.51
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	74162.48	74940.08	1.05
Cash	98468.57	116703.13	18.52
Capex	-136.34	-72.81	46.60
Free Cash Flow	895.24	26803.58	2894.03
Revenue	7604.51	41686.36	448.18
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.05	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	95.59	54.86	-42.62
Naive Interpretation	Member

06 - Financial Health · Bad

Rating